Search results
LIC raises stake in IDFC First Bank to 2.68% at ₹80.63/share via private placement offer | Mint
Livemint· 1 day agoLIC raised its stake in IDFC First Bank to 2.68% at ₹80.63 per share via a private placement offer...
Macquarie Capital rates HDFC Bank a 'buy', sees this potential near-term trigger - CNBC TV18
CNBC TV18· 3 days agoSuresh Ganapathy, banking analyst at Macquarie Capital Securities expressed a cautious stance on ...
Niva Bupa Health Insurance files draft papers with Sebi to launch Rs 3,000 crore IPO
Business Today· 4 days agoNiva Bupa Health Insurance is one of largest and fastest growing standalone retail health insurers...
What CJI Chandrachud's ‘stratospheric’ market remark means for equity markets
The Economic Times· 45 minutes agoIndian headline indices' record hitting spree has raised alarm bells among sections of market...
Bajaj Finance can become best pick in financial space amongst largecaps in one or two quarters:...
The Economic Times· 1 day agoWhatever growth will pick up will probably happen on the infra corporate side. HDFC is not known to...
Bain Capital-backed Emcure Pharma mobilises Rs 583 Cr from anchor investors
YourStory· 2 days ago...Prudential MF, SBI MF, Nippon India MF, Abu Dhabi Investment Authority, Goldman Sachs Asset Management, Nomura, HDFC Life Insurance Company, ICICI Prudential Life Insurance Company and, SBI Life Insurance Company.
Market cap tracker: Reliance, HDFC Bank gain most among Top 10 post-election; LIC, ITC lose
The Week· 4 days agoAmong the Top 10 companies, Reliance Industries saw the most gains, along with seven other firms. ...
Share market update: Most active stocks of the day in terms of total traded value
The Economic Times· 3 days agoThe NSE Nifty index was trading 13.25 points down at 24128.7
Emcure Pharma Backed By Bain Capital Mobilises ₹583 Crore From Anchor Investors
Free Press Journal· 2 days agoBain Capital-backed Emcure Pharmaceuticals on Tuesday said it has garnered Rs 583 crore from anchor...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 1 day agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...